Chondroitin
Cartilage component, usually from bovine or shark cartilage and often combined with glucosamine.
What the research shows
No sound research in humans.
The Cochrane review by Singh (2015) saw a small reduction in pain that largely disappeared once only trials at low risk of bias were counted. Wandel (2010) reached the same picture and reported that commercially funded trials showed larger effects than independent ones. Meng (2023) found no convincing added benefit for the combination with glucosamine.
Who it makes sense for: Almost nobody: in the best-designed trials little of the pain effect remains.
How we weigh evidenceClinical dosage
Scientific sources
The clinical dosages on this page are based on peer-reviewed research.
- Chondroitin for osteoarthritis.Singh JA et al. (2015)Funded by: Hoofdauteur meldt onderzoeksbeurzen van Takeda en Savient en consultancyvergoedingen van Savient, Takeda, Allergan en Regeneron (geen chondroitineproducenten).
- Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.Wandel S et al. (2010)
- Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis.Meng Z et al. (2023)
We keep the dosages and values on this page as accurate as possible based on selected studies. New research may change these values. Nothing on this page is medical advice. If you have any doubts, always consult a doctor.